Absco Therapeutics, Inc. — Form D
Absco Therapeutics, Inc. of ALLSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-27. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-08-27
- Form: D
- Accession: 0002023557-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2025-08-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-556003
Issuer
- Name: Absco Therapeutics, Inc.
- CIK: 0002023557
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 127 WESTERN AVENUE, ALLSTON, MA, 02134
- Phone: 314-917-7620
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Stephen Linderman | Director | Allston, MA |
| Avik Som | Director | Allston, MA |
| Carlo Giovanni Traverso | Director | Allston, MA |
| Stephen Linderman | Executive Officer | Allston, MA |
Other filings by this issuer (1)
More